- Home
- Skills
- Trading & Investing
- NSE/BSE Research Desk: Sourced Indian Stock Dossiers
More screenshots
Works with the AI Agents you already use
NSE/BSE Research Desk: Sourced Indian Stock Dossiers
Ask a plain AI model instead and you get confident numbers with no way to tell which ones are real.
$9.99
NSE/BSE Research Desk: Sourced Indian Stock Dossiers
Example session with this skill installed
Build me a research dossier on Pidilite Industries (NSE: PIDILITIND). I want the business, the financials, who owns it and whether the promoters have pledged shares, any red flags, and a sensible valuation range.
- Read your context and instructions
- Compiled the nse bse research
- Generated the document
Pidilite Industries Ltd (NSE: PIDILITIND, BSE: 500331)
Research dossier, compiled 7 Nov 2026. Amounts are in Rs crore (Rs cr) unless stated. Figures are consolidated.
Bottom line
- Pidilite is India's largest maker of consumer adhesives and sealants (Fevicol, Dr Fixit, M-seal). It has almost no debt, has kept its AAA credit rating, and its promoters have pledged no shares.
- In H1 FY27 (Apr–Sep 2026) revenue grew about 21%, from price increases plus about 11% volume growth. But in Q2 FY27 the EBITDA margin fell from about 24% to about 20% as raw material costs rose, so profit grew only 7%.
- The biggest open risk is valuation. At about 60x trailing earnings, the share price already assumes about 25% a year earnings growth for 10 years. Over FY22–26 profit grew about 20% a year and revenue about 10%.
1. Snapshot
| Item | Value | Src |
|---|---|---|
| ISIN | INE318A01026 | [1] |
| Sector | Chemicals (adhesives, sealants, construction chemicals) | [1][5] |
| Price (6 Nov 2026, 15:59 IST) | Rs 1,579.00 | [1][2] |
| Market cap (6 Nov 2026) | Rs 1,60,522 cr | [1] |
| 52-week high / low | Rs 1,707.50 / 1,259.00 | [1] |
| TTM EPS (four quarters to Sep 2026) | Rs 26.36 | [2] |
| TTM P/E | 59.9x (calc: 1,579 [1] ÷ 26.36 [2]) | calc |
Screener [2] gives the market cap as Rs 1,60,827 cr, a small difference from Upstox [1]. A 1:1 bonus issue had a record date of 23 Sep 2025 [11]. All per-share figures here are on the post-bonus basis of about 101.7 crore shares (calc: market cap ÷ price [1]).
2. Business
Pidilite started in 1969 with pigment emulsions and adhesives. It now runs two segments [5]:
Consumer & Bazaar (C&B): branded adhesives, sealants, waterproofing and art materials, sold through more than 5,050 distributors. This was about 81% of FY25 sales [5].
- Business-to-business (B2B): industrial specialty chemicals, about 18.4% of FY25 standalone revenue [5].
Brands include Fevicol, Fevikwik, Fevistik, Dr Fixit, M-seal, Steelgrip and Fevicryl. The company has 33 plants [5]. CRISIL calls it "the market leader in the domestic adhesives and sealants industry". It gives no market share figure and names only "unorganised players" as competitors [5]. I did not find a list of listed competitors.
Exports were about 3.7% of consolidated revenue in FY25 [5]. Overseas subsidiaries (Middle East, South Asia, Africa, Thailand) are "weak but improving", with an EBITDA margin of 14.2% in FY25 [5]. The company has exited Brazil and the Americas [5].
3. Financials (consolidated)
| FY | Revenue | EBITDA % | Net profit |
|---|---|---|---|
| FY22 | 9,921 | 19% | 1,207 |
| FY23 | 11,799 | 17% | 1,289 |
| FY24 | 12,383 | 22% | 1,747 |
| FY25 | 13,140 | 23% | 2,096 |
| FY26 | 14,601 | 24% | 2,471 |
Source for all rows: [2]. EBITDA % is Screener's operating profit margin.
| FY | EPS (Rs) | Cash from ops | ROCE |
|---|---|---|---|
| FY22 | 11.88 | 955 | 25% |
| FY23 | 12.52 | 1,558 | 24% |
| FY24 | 17.00 | 2,724 | 30% |
| FY25 | 20.41 | 2,287 | 30% |
| FY26 | 24.06 | 2,828 | 31% |
Source for all rows: [2].
Net cash. At Mar 2026, borrowings were 417 and investments 4,350 [2], so net cash was about 3,933 (calc). Some investments may be strategic stakes rather than cash. CRISIL put unencumbered liquid surplus at 3,474 at Mar 2025 [5].
- Returns. ROE is 23.9% [2].
Trend. From FY22 to FY26, revenue grew about 10.1% a year and profit about 19.6% a year (calc from [2]). Most of the extra profit growth came from the margin rising from 17–19% to 24%, which cannot keep compounding.
Cross-check. The company's own site gives FY26 PAT (profit after tax) of 2,470.7 [10], which matches. It gives net sales of 14,553 against revenue of 14,601 on Screener and 14,600.83 on Upstox [1]. The gap is a definition difference (net sales versus revenue from operations).
Q2 FY27 (Sep 2026) vs Q2 FY26 (Sep 2025) [2]:
- Revenue 4,298 vs 3,554 (+20.9%, calc).
- EBITDA 877 vs 850. Margin 20.4% vs 23.9% (calc).
- Net profit 626 vs 585 (+7.0%, calc).
- 5paisa reports revenue of 4,285, EBITDA margin 20.5% and profit +7% [6].
- Volume growth was 11.1% in C&B and 9.2% in B2B [6]. Material costs rose from about 45% to about 52% of net sales [19s].
Q1 FY27 (Jun 2026): revenue 4,552 (+21.3%), net profit 884 (+30%), margin 26% [2][9s]. The company raised prices by 2–12% across categories during Q1 to offset crude-linked input inflation [7]. FY27 revenue growth guidance is 14–15% [8], and medium-term EBITDA margin guidance is 20–24% [7].
4. Shareholding and pledges
| Holder | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoter | 69.32% | 69.32% | 69.24% | 69.19% |
| FPI | 12.01% | 11.75% | 11.69% | 12.42% |
| DII | 9.21% | 9.56% | 9.81% | 9.21% |
| Public | 9.40% | 9.29% | 9.18% | 9.20% |
Source: Screener [2]. Trendlyne [3] and Upstox [4] agree within 0.01 percentage points; for example, both show the promoter at 69.18% for Sep 2026.
Pledge (promoter shares given as loan collateral): 0.0% of promoter holding, which is also 0.0% of total shares, in every quarter from Dec 2024 to Sep 2026 [3]. Promoters hold 704,658,560 shares [3]. The BSE shareholding page refused automated access (HTTP 403), so I could only confirm the pledge figure from one aggregator, not from the exchange filing itself.
Mutual funds cut their holding from 4.56% to 3.92% over the four quarters. FPIs added 0.7 points in the Sep 2026 quarter [3].
5. Filings and events (last 12 months)
2 Sep 2025 (just outside the window): CRISIL reaffirmed its ratings at AAA/Stable (long-term) and A1+ (short-term) [5]. I found no 2026 rationale.
- 23 Sep 2025: record date for the 1:1 bonus issue [11].
- Dec 2025: subsidiary Nina Percept received a Rs 1.97 cr GST penalty order [12s].
3 Feb 2026: Q3 FY26 results.
7 May 2026: Q4 FY26 results.
4 Aug 2026: Q1 FY27 results. All dates are from the company's press release page [10].
- 24 Mar 2026: GST penalty orders totalling Rs 12.10 cr. The company said it would appeal [12s].
Jun–Jul 2026: further small GST orders, including Rs 46.98 lakh in Madhya Pradesh. The company called them not material and appealable [12s].
2026, date not confirmed: the company plans to take full ownership of Pidilite C-Techos Walling. Separately, a subsidiary swapped its Pepperfry stake for shares of TCC Concept [18s].
- 29 Oct 2026: Q2 FY27 results and earnings call [6].
Management: Sudhanshu Vats became Managing Director in April 2025 [10]. I found no CFO or company secretary change in 2026.
6. Red flags
Found:
#17 Regulatory action. There is a repeated run of GST penalty orders, the largest being Rs 12.10 cr in Mar 2026 [12s]. Possible innocent reading: that is about 0.5% of FY26 PAT (calc), and the orders are under appeal. Routine GST disputes are common for companies selling across India.
Watch (not a breach of the thresholds):
- Debtor days rose from 47 in FY23 to 55 in FY26, up 17%, just under the 20% threshold [2].
- The Q2 FY27 margin fell by about 350 basis points [2][19s].
Clear:
- #1 Pledge: 0% [3].
- #2 Promoter holding: down only 0.13 points in four quarters [2].
- #3 Low promoter holding: promoters own 69% [2].
- #4 Cash vs profit: five-year cash from operations is 117% of net profit (calc: 10,352 ÷ 8,810 [2]).
- #6 Inventory: inventory days were 98 in both FY23 and FY26 [2].
- #7 Other income: 7.5% of profit before tax (calc: 248 ÷ 3,320 [2]).
- #9 Capitalised costs: capital work in progress of 329 is small against revenue of 14,601 [2].
- #10 Leverage: debt is 0.12x EBITDA, and interest cover is about 62x (calc [2]).
- #13 Dilution: the doubling of equity capital came from the bonus issue, not new shares sold [2][11].
- #15 Management exits: no exits in the window [10].
- #16 Credit rating: AAA/Stable [5].
#21 Guidance: FY26 revenue growth was 11.1% (calc [2]). This only weakly confirms the FY26 guidance was met (see Open questions).
Not checked:
#8, #11, #12, #14: these need the FY26 annual report notes (exceptional items, contingent liabilities, related-party transactions, auditor opinion). I downloaded the PDF but could not extract its text.
- #18 Surveillance (ASM/GSM): I found no page that confirms either way.
- #19 Late filings or fines: results dates look normal, but I did not search for exchange fines.
- #20 Customer or supplier concentration: not disclosed in anything I read.
7. Valuation range
Method 1: P/E band on TTM EPS of Rs 26.36 [2].
| Case | P/E | Value/share | Basis |
|---|---|---|---|
| Low | 60.6x | Rs 1,597 | P/E on 22 Sep 2026 [14s] |
| Base | 72.1x | Rs 1,901 | 10-year median [14s] |
| High | 89.8x | Rs 2,367 | 5-year median [13s] |
The 5-year P/E range runs from 69.4x (2025) to 103.3x (2022) [13s], which gives Rs 1,829 to 2,724 (calc). I have not used the top of that range as a case. Those multiples come from a period of low interest rates. The India 10-year bond yield is now 7.40% (29 Oct 2026) [15s], after RBI rate hikes.
Method 2: reverse DCF (what growth the price implies).
- Starting cash flow: TTM PAT of 2,718 [2].
- Market value of operations: market cap 1,60,522 [1] minus net cash 3,933 (calc).
- Discount rate: 12.4–12.9% (the 7.40% bond yield [15s] plus a 5.0–5.5 point equity risk premium).
- Terminal growth: 5%.
- Result: the price implies about 24.5–25.5% a year earnings growth for 10 years (calc).
- If I start instead from free cash flow (cash from operations of 2,828 [2] minus CRISIL's expected yearly capex of about 700 [5], so about 2,128), the price implies about 29% a year (calc).
- Over FY22–26, profit grew 19.6% a year and revenue 10.1% (calc). Against those, the implied growth looks
demanding.
Where the price sits: the current price of Rs 1,579 (6 Nov 2026) [1] is at the low end of the historical P/E band. The cash-flow method says even that price already assumes strong growth.
What moves the range most:
1.
EBITDA margin. Q2 FY27 was 20.4% against 24% for FY26. The direction depends on crude-linked input costs and whether price increases stick.
2. The P/E multiple. It moves with bond yields.
3. Volume growth. Can C&B keep growing at low double digits?
8. Open questions
- FY26 annual report notes: contingent liabilities, related-party transactions with the Parekh family entities, auditor opinion and any exceptional items.
- The pledge and shareholding figures in the exchange filing itself, rather than aggregators.
- Whether Q3 FY27 margins recover towards the 20–24% guidance [7], or input costs keep squeezing them.
- Whether there is a newer CRISIL or ICRA rating action than Sep 2025.
- The terms and value of the C-Techos buy-out and the Pepperfry/TCC swap.
9. Sources
Sources marked
s were seen only as search-engine extracts; I did not open the page in full. Treat their figures as lower confidence.
- [1] Upstox, Pidilite share price page, https://upstox.com/stocks/pidilite-industries-ltd-share-price/INE318A01026. Period: price at 6 Nov 2026, 15:59 IST. Read 7 Nov 2026.
- [2] Screener.in, Pidilite consolidated, https://www.screener.in/company/PIDILITIND/consolidated/. Period: FY22–FY26, quarters to Sep 2026, close of 6 Nov. Read 7 Nov 2026.
- [3] Trendlyne, shareholding, https://trendlyne.com/equity/share-holding/1037/PIDILITIND/latest/pidilite-industries-ltd (plus the 31-12-2025 and 31-03-2026 pages). Period: Dec 2025–Sep 2026. Read 7 Nov 2026.
- [4] Upstox, shareholding, https://upstox.com/stocks/pidilite-industries-ltd-shareholding/. Period: to Sep 2026 (page as on 6 Nov 2026). Read 7 Nov 2026.
- [5] CRISIL Ratings, rating rationale, https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/PidiliteIndustriesLimited_September%2002_%202025_RR_376045.html. Period: FY25 (dated 2 Sep 2025). Read 7 Nov 2026.
- [6] 5paisa, Pidilite Q2 results, https://www.5paisa.com/blog/pidilite-industries-q2-results-profit-revenue-ebitda-fy27. Period: Q2 FY27 (updated 29 Oct 2026). Read 7 Nov 2026.
- [7] Sahi, "Pidilite maintains 20–24% margin target…", https://www.sahi.com/news/pidilite-maintains-20-24-margin-target-amid-strong-demand-despite-price-hikes-1252-PE1_COR. Period: Q1 FY27 (8 Aug 2026). Read 7 Nov 2026. The page notes it may be AI-assisted.
- [8] Sahi, "Pidilite nears low-teen volume growth…", https://www.sahi.com/news/pidilite-nears-low-teen-volume-growth-targets-14-15-revenue-growth. Period: FY27 guidance (24 Sep 2026). Read 7 Nov 2026.
- [9s] Free Press Journal, Q1 FY27 results, https://freepressjournal.in/business/pidilite-industries-reports-88351-crore-net-profit-in-q1-fy27-up-3028-yoy. Period: Q1 FY27. Read 7 Nov 2026.
- [10] Pidilite investor relations and press release pages, https://www.pidilite.com/investor-relations and https://www.pidilite.com/media/press-release. Period: FY26 highlights and results dates. Read 7 Nov 2026.
- [11s] Angel One, bonus record date, https://www.angelone.in/news/market-updates/pidilite-industries-1-1-bonus-issue-fixed-september-23-as-record-date. Period: Sep 2025. Read 7 Nov 2026.
- [12s] GST orders:
- Whalesbook, https://www.whalesbook.com/corporate-news/English/chemicals/Pidilite-Hit-By-indian-rupee1210-Crore-GST-Penalties-Company-Vows-to-Appeal/69c3d5b149d6b264f25c3f9d (Mar 2026).
- NSE filing, https://nsearchives.nseindia.com/corporate/Nisha_22072026145020_SEIntimationOrderMPJuly2026signed.pdf (Jul 2026).
- TipRanks, https://www.tipranks.com/news/company-announcements/pidilites-subsidiary-faces-gst-penalty-with-no-major-impact-on-operations (Nina Percept).
- All read 7 Nov 2026.
- [13s] Wisesheets, P/E history, https://www.wisesheets.io/pe-ratio/PIDILITIND.BO. Period: 2021–2025. Read 7 Nov 2026.
- [14s] GuruFocus, P/E (TTM), https://www.gurufocus.com/term/pettm/NSE:PIDILITIND. Period: as of 22 Sep 2026, plus 10-year median. Read 7 Nov 2026.
- [15s] Trading Economics, India 10-year yield, https://tradingeconomics.com/india/government-bond-yield/news/592252. Period: 29 Oct 2026. Read 7 Nov 2026.
- [18s] ScanX, C-Techos and Pepperfry items:
- https://scanx.trade/stock-market-news/corporate-actions/pidilite-industries-to-acquire-full-ownership-of-pidilite-c-techos-walling/23379926
- https://scanx.trade/stock-market-news/orders-deals/pidilite-industries-subsidiary-completes-share-swap-transaction-with-tcc-concept/29246673
- Period: 2026, date unconfirmed. Read 7 Nov 2026.
- [19s] IndMoney, Q2 margin analysis, https://www.indmoney.com/blog/stocks/pidilite-q2-results-margin-pressure. Period: Q2 FY27. Read 7 Nov 2026.
10. Disclaimer
This dossier is research compiled from public web sources for
information only. It is not investment advice, a recommendation to buy,
sell or hold any security, or a research report under SEBI (Research
Analysts) Regulations. Figures may be out of date or wrong; check the
cited sources and consult a SEBI-registered adviser before investing.
Limits of this research:
- I could not read Pidilite's own PDFs (the FY26 annual report and quarterly press releases), so four red-flag items are marked not checked.
- BSE refused automated access, so the pledge figure comes from one aggregator, not the exchange filing.
- Several sources (marked s) were seen only as search extracts. Check them before relying on them.
202025_RR_376045.html
PDF · document
Example file from a real run - the skill writes it into your workspace.
Connects securely to your tools. The creator never sees your data.
About this skill
Researching an Indian stock usually means ten browser tabs: the exchange quote page, the annual report PDF, a shareholding pattern, a rating rationale, an aggregator's ten-year table. Ask a plain AI model instead and you get confident numbers with no way to tell which ones are real.
NSE/BSE Research Desk fixes the second problem and speeds up the first. Ask
for one company by name, NSE symbol or BSE code, and the agent reads public
web pages and writes a dossier where every figure has a numbered
citation with its URL, the period it covers and the date it was read.
Ratios it works out itself are marked calc with their inputs. Anything it
could not find on a page it read says not found instead of a guess.
What the dossier covers
- Snapshot: symbol, ISIN, sector, dated price and market cap.
- Business: segments, revenue mix, competitors.
- Financials: five fiscal years plus the latest quarter, with revenue, margins, profit, cash from operations, net debt and ROCE.
- Shareholding and pledges: promoter, FPI, DII and public over four quarters; pledged shares as a % of promoter holding and of equity.
- Filings and events from the last 12 months, each dated.
- A 21-point red-flag screen built for Indian filings (pledges, cash versus profit, related parties, auditor exits, rating actions, ASM/GSM surveillance). Each item is marked found, clear or not checked.
- A valuation range from at least two methods (multiple band and a reverse DCF) with low, base and high cases.
- Open questions to check next, the source list and a disclaimer.
It also handles narrow asks ("just the pledge position for X") with the same sourcing rules.
Requires: an agent that loads SKILL.md skills (Claude Code or another Agent Skills compatible agent) with web search and web page reading turned on. No API keys, broker logins or paid data feeds. The package is text only: no scripts, no local file access.
Known limitations
- It reads what public pages show. Exchange sites sometimes load data with scripts that page readers can't see; the agent then falls back to PDFs, the company site or aggregators and says which it used.
- Data is only as fresh as the pages it finds. Prices and shareholding are dated so you can see how old they are.
- A typical dossier takes several minutes and many web reads.
- It is not a SEBI-registered research report. It never says buy, sell or hold and never gives a single price target.
- Banks and NBFCs get price-to-book based valuation; very new listings may lack five years of history.
FAQ
Can I trust the numbers? Trust the citations, not the prose: each figure links to the page it came from, so you can check any line in seconds.
Does it give buy or sell calls? No. You get facts, flags and a range under stated assumptions.
Does it work for SME or small caps? Yes, though thinly covered
companies return more not found entries, shown honestly.
Does it read my files or portfolio? No. Public web pages only.
Find more skills like this on the Claude Skills Marketplace, the Codex Skills Marketplace and the Gemini Skills Marketplace, or browse Claude Skills for Trading & Investing.
It reads what public pages show. Exchange sites sometimes load data with scripts that page readers can't see; the agent then falls back to PDFs, the company site or aggregators and says which it used. Data is only as fresh as the pages it finds. Prices and shareholding are dated so you can see how old they are. A typical dossier takes several minutes and many web reads. It is not a SEBI-registered research report. It never says buy, sell or hold and never gives a single price target. Banks and NBFCs get price-to-book based valuation; very new listings may lack five years of history.
How to use
- 1
Connect your agent to the Agensi MCP
Copy the prompt and paste it into Claude, ChatGPT, Cursor or any agent that supports MCP. It sets up the connection for you. Manual setup
- 2
Sign in to Agensi
Your agent shows a sign-in link. Sign in and click Allow.
- 3
Ask for what you need
Your agent loads this skill and uses it on your task. It always asks before buying a skill.
Reviews
No reviews yet
Be one of the first to try it. Every listed skill goes through the trust checks below.
Security scanned
Checked by our 8-point scan before listing
Fresh listing
Recently published to Agensi
Money-back guarantee
Doesn't do what its page promises? You get your money back.
Trust & safety
Security scan
Security scan passed 9 days ago
- Software
- Web searchWeb page reading